CIT v. Claris Lifesciences Ltd.

326 ITR 251High Court2010#476 most cited

What is CIT v. Claris Lifesciences Ltd. authority for?

If approval from the Department of Scientific and Industrial Research (DSIR) for an in-house R&D centre is granted during the previous year, the assessee is entitled to claim weighted deduction under section 35(2AB) for the entire expenditure incurred during that year.

196

judgments rely on this decision, according to BharatTax’s citation analysis of 366,406 Indian tax judgments — from 2011 to 2026.

Also referred to as

CIT v. Claris Lifesciences Ltd. · 326 ITR 251 · Section 35(2AB) · weighted deduction · scientific research expenditure · R&D centre approval · DSIR approval timing · eligibility for entire expenditure · in-house R&D · previous year expenditure

Also reported as

174 Taxmann 11320 Taxmann.com 682

Issues it is cited on

Judgments citing CIT v. Claris Lifesciences Ltd.

DCIT, Circle-4(2), New Delhi vs. Curadev Pharma P.Ltd, Delhi

In the result, appeal of the assessee is partly allowed

ITA 1260/DEL/2022[2016-17]Status: DisposedITAT Delhi17 Apr 2026AY 2016-17

Bench: Shri Anubhav Sharma & Shri Manish Agarwal[Assessment Year : 2016-17] Dcit Vs Curadev Pharma Pvt. Ltd., Circle-4(2) 1St Floor, Vikash Puri, New Delhi West Delhi, Delhi-110018 Pan-Aadcc8368D Appellant Respondent Revenue By Ms. Pooja Swaroop, Cit Dr Appellant By Shri Mukesh Jain, Ca & Shri Samyak Jain, Adv. [Assessment Year : 2018-19] Curadev Pharma Pvt. Ltd., Vs Ito H-3/63, 1St Floor, Vikash Nfac, Delhi Puri, New Delhi-110018 Pan-Aadcc8368D Appellant Respondent [Assessment Year : 2020-21] Curadev Pharma Pvt. Ltd., Vs Dcit H-3/63, 1St Floor, Vikash Central Circle-4(2), Puri, New Delhi-110018 Delhi Pan-Aadcc8368D Appellant Respondent Appellant By Shri Mukesh Jain, Ca & Shri Samyak Jain, Adv. Revenue By Shri Rajesh Kumar Dhanesta, Sr.Dr Date Of Hearing 29.01.2026 Date Of Pronouncement 17.04.2026

Section 126Section 139(1)Section 143(2)Section 250Section 35Section 37(1)

…o- ordinate Bench of Ahmedabad Tribunal in the case of ACIT vs Torrent Pharmaceuticals Ltd. in ITA No.3569/Ahd/2004 vide order dated 13.11.2009 and further the judgement of Hon’ble Gujarat High Court in the case of CIT vs Claris Life Sciences Ltd. reported in 326 ITR 251 (Guj.). Ld. AR further submits that amendment in section 35(2AB) regarding approval from Ld. PCIT or DGIT for scientific research expenditure and weighted deduction u/s 35(2AB) of the Act are applicable from 01.07.2016 relevant to AY 2017-18 onwards and not applicable for AY 2016-17 i.e. the year under appeal. He thus, submits that remuneration p…

Ashok Leyland Limited, Chennai vs. ACIT, Chennai

ITA 2330/CHNY/2019[2015-16]Status: DisposedITAT Chennai07 Jul 2025AY 2015-16

Bench: Shri Aby T. Varkey & Shri Amitabh Shuklaआयकर अपील सं./Ita No.2330/Chny/2019 निर्धारण वर्ष/Assessment Year: 2015-16 M/S. Ashok Leyland Ltd., 1, Sardar Patel Road, Guindy, Chennai-600 032. [Pan: Aaaca 4651 L] (अपीलार्थी/Appellant) V. The Acit, Large Taxpayer Unit-2, Chennai. (प्रत्यर्थी/Respondent) आयकर अपील सं./Ita No.2618/Chny/2019 निर्धारण वर्ष/Assessment Year: 2015-16 The Acit, Large Taxpayer Unit-2, Chennai. V. M/S. Ashok Leyland Ltd., 1, Sardar Patel Road, Guindy, Chennai-600 032. [Pan: Aaaca 4651 L] (अपीलार्थी/Appellant) (प्रत्यर्थी/Respondent) Assessee By : Mr.R. Vijayaraghavan, Adv. & Mr.Vikram Vijayaraghavan, Adv. Department By : Mr.A. Sasikumar, Cit सुनवाईकीतारीख/Date Of Hearing : 02.05.2025 घोषणाकीतारीख /Date Of Pronouncement : 07.07.2025

For Appellant: Mr.R. Vijayaraghavan, AdvFor Respondent: Mr.A. Sasikumar, CIT
Section 115JSection 143(3)Section 14A

…Ltd., v. DCIT (ITA No.3236/Chny/2017) in para no. 4.3 on page 12 ITA Nos.2330 & 2618/Chny/2019 (AY 2015-16) M/s. Ashok Leyland Ltd. :: 14 :: - ACIT vs. v. Crompton Greaves Ltd. [2019] 111 taxmann.com 338 (Mumbai - Trib.) - CIT v. M/s. Wheels India Ltd. [2011] 336 ITR 513 (Madras) (AY 2012- 13) - Brakes India Limited vs. DCIT [2017] 56 ITR(T) 341 (Chennai -Trib.)" 6.4 In light of the above therefore, we hold that the lower authorities were not justified in curtailing the deduction u/s 35(2AB) in the pre- amended pre period and direct deletion of the disallowance of the weighted deduction of Rs.2,47,62,660/-. This…

The ACIT, Circle-2(1)(1), Ahmedabad vs. M/S. Intas Pharmaceuticals Ltd., Ahmedabad

Accordingly, this ground raised by the Revenue is dismissed

ITA 281/AHD/2021[2015-16]Status: DisposedITAT Ahmedabad21 May 2025AY 2015-16

Bench: S/Shri T.R. Senthil Kumar & Makarand V.Mahadeokarasstt.Year : 2015-16 Acit, Cir.2(1)(1) M/S.Intas Pharmaceuticals Ltd Vejalpur Vs Corporate House Ahmedabad. S.G. Highway Nr.Sola Bridge, Thaltej Ahmedabad 380 054. Pan : Aaaci 5120 L Asstt.Year : 2015-16 M/S.Intas Pharmaceuticals Ltd Acit, Cir.2(1)(1) Corporate House Vs Vejalpur S.G. Highway Ahmedabad. Nr.Sola Bridge, Thaltej Ahmedabad 380 054. Pan : Aaaci 5120 L (Applicant) (Responent) : Assessee By Shri S.N. Soparkar, Sr.Advocae & Shri Parin Shah, Ar : Shri Ragnesh Das, Cit-Dr Revenue By सुनवाई क" तारीख/Date Of Hearing : 28/04/2025 घोषणा क" तारीख /Date Of Pronouncement: 21/05/2025 आदेश आदेश/O R D E R आदेश आदेश

Section 115JSection 142(1)Section 143(2)Section 143(3)Section 144CSection 14ASection 35Section 36(1)(iii)Section 37Section 92C

…as placed on the decisions of the Coordinate Bench in assessee’s own case for A.Ys. 2013–14 and 2014–15 in ITA No. ITA No.281 and 222/Ahd/2021 18 400/Ahd/2018, as well as on the decisions of the Hon’ble Gujarat High Court in Claris Lifesciences Ltd. [(2010) 326 ITR 251 (Guj)] and Cadila Healthcare Ltd. [(2013) 31 taxmann.com 300 (Guj)]. 23. In the said decision in assessee’s own case, the Co-ordinate Bench has extensively examined the scope of DSIR’s authority, the applicability of Rule 6(7A), and the evidentiary value of Form 3CL. It has been held that the Form 3CL merely reflects intimation of cost of in-hou…